If CSE IPO's the Healthcare REIT and retains a large position, how would the valuation of the retained portion be handled? The transaction will provide a market valuation for the retained shares which might be a book up creating a healthier balance sheet not to mention cash flow from the REIT.
The renegatiation is for existing loans of CSE that are on the revolvers with their lenders. Yes - those lenders have been renegotiating their rates higher and are likely to continue to do so as these short term revolver lines terms expire.
But CSE's loan volume on these revolvers will shrink by 2.2b after they sell the 2.2b to the new CSE Bank.
New CSE Bank has a reserve ratio of 15% according to the filings. So after the new CSE Bank purchases loans from subsidiary CSE, and after also subtracting the reserve ratio of 850m, and subtracting about 500m in liabilities from FIL purchased commercial loans, the new CSE Bank will have about $2B in capital to make fresh loans.
These new loans by new CSE Bank will have much lower cost of funds, about 3.5% paid to the depositors, versus the rising cost of funds from CSE's higher priced revolving lines of credit, about libor plus 4 = about 7.5%. New CSE Bank by my calculations will have $2b to make new loans at much better spreads than CSE. CSE will likley let much of the revolver lines bleed off as repayments occur.